February 27, 2020 / 6:20 AM / a month ago

BRIEF-Basilea First Milestone Payment Related To Launch Of Antifungal Cresemba In Australia

Feb 27 (Reuters) - Basilea Pharmaceutica AG:

* BASILEA REPORTS THE LAUNCH OF ANTIFUNGAL CRESEMBA® (ISAVUCONAZOLE) IN AUSTRALIA TRIGGERING THE FIRST MILESTONE PAYMENT RELATED TO ASIA-PACIFIC

* BASILEA PHARMACEUTICA AG - LAUNCH TRIGGERED FIRST MILESTONE PAYMENT (USD 0.5 MILLION) RELATED TO ASIA-PACIFIC TERRITORY FROM PFIZER TO BASILEA Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below